| RS2107624989 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS2107625030 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107625491 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107626681 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107626695 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107627423 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia 1, Neonatal severe primary hyperparathyroidism |
| RS2107627458 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107627594 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107627659 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2107627671 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2107627809 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hyperparathyroidism or Hypocalciuric hypercalcaemia, Familial hyperparathyroidism or Hypocalciuric hypercalcaemia |
| RS2107627915 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS2107628480 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107628870 |
LAMB2
|
Health Risk |
Pathogenic |
LAMB2-related infantile-onset nephrotic syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS2107630477 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107631188 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107631431 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107631669 |
PLXNA1
|
Health Risk |
Pathogenic |
— |
| RS2107631736 |
CASR
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2107631756 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107631757 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107631801 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107631937 |
COL7A1
|
Health Risk |
Pathogenic |
Pretibial dystrophic epidermolysis bullosa, Pretibial dystrophic epidermolysis bullosa |
| RS2107631988 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, COL7A1-related disorder |
| RS2107632018 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107632061 |
CASR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107632066 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrolithiasis/nephrocalcinosis, Familial hypocalciuric hypercalcemia 1 |
| RS2107632158 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107632493 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107632517 |
CASR
|
Health Risk |
Pathogenic |
— |
| RS2107632553 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107632563 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107632620 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107632814 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107632817 |
CASR
|
Health Risk |
Likely pathogenic |
— |
| RS2107632822 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107632852 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2107632860 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107633334 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107633400 |
COL7A1
|
Health Risk |
Pathogenic |
COL7A1-related disorder, COL7A1-related disorder |
| RS2107635006 |
COL7A1
|
Health Risk |
Pathogenic |
7 conditions, 7 conditions |
| RS2107635110 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107635149 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107635603 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107636063 |
LAMB2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS2107636494 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107636603 |
COL7A1
|
Health Risk |
Pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107636606 |
COL7A1
|
Health Risk |
Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107636803 |
ACAD9
|
Health Risk |
Pathogenic |
— |
| RS2107637140 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107637340 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107637442 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107638414 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107638542 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107638590 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107638673 |
LAMB2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMB2-related infantile-onset nephrotic syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS2107639217 |
LAMB2
|
Health Risk |
Likely pathogenic |
Pierson syndrome, Pierson syndrome |
| RS2107639630 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107639823 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107641650 |
SEC61A1
|
Health Risk |
Pathogenic |
Hyperuricemic nephropathy, familial juvenile type 4 |
| RS2107641787 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, COL7A1-related disorder |
| RS2107642565 |
COL7A1
|
Health Risk |
Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107642953 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107643014 |
LAMB2
|
Health Risk |
Likely pathogenic |
Pierson syndrome, Pierson syndrome |
| RS2107643346 |
LAMB2
|
Health Risk |
Pathogenic |
Pierson syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS2107643652 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107643705 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107644554 |
ARHGAP31
|
Health Risk |
Likely pathogenic |
Cerebral palsy, Cerebral palsy |
| RS2107644932 |
ILDR1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 42, Autosomal recessive nonsyndromic hearing loss 42 |
| RS2107645768 |
LAMB2
|
Health Risk |
Likely pathogenic |
Pierson syndrome, Pierson syndrome |
| RS2107646414 |
SETD2
|
Health Risk |
Pathogenic |
— |
| RS2107648261 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107648305 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS2107648387 |
CASR
|
Health Risk |
Pathogenic |
Nephrolithiasis/nephrocalcinosis, Nephrolithiasis/nephrocalcinosis |
| RS2107648492 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107648722 |
ACAD9
|
Health Risk |
Pathogenic |
— |
| RS2107648799 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2107649366 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107649385 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107649406 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107649423 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107649518 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2107649591 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2107649818 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107649847 |
CASR
|
Health Risk |
Likely pathogenic |
— |
| RS2107649885 |
CASR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107650029 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2107650046 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia 1, Autosomal dominant hypocalcemia 1 |
| RS2107650135 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2107650195 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107650280 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107650417 |
CASR
|
Health Risk |
Pathogenic |
— |
| RS2107650472 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107650518 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2107650603 |
CASR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107650629 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS2107650645 |
CASR
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Autosomal dominant hypocalcemia 1 |
| RS2107650671 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107651058 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2107651172 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |